[TRENDING NEWS] In a Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug
Author: BY REBECCA ROBBINS AND PAM BELLUCK - Publish Date: July 9, 2021 at 12:54AM
The agency faced criticism for approving Aduhelm for all Alzheimer’s patients. The new label recommends that the drug be given only to patients with mild symptoms.
The agency faced criticism for approving Aduhelm for all Alzheimer’s patients. The new label recommends that the drug be given only to patients with mild symptoms.